The present disclosure provides for improved methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using alpha-adrenergic antagonists and beta-adrenergic agonists (particularly beta2-adrenergic agonists) alone or in combination.
Alpha and/or beta-adrenergic antagonists and agonists to treat pain